| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.26 | 2e-12 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-09 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-09 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-08 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.2 | 6e-08 |